Favorable pharmacokinetics and pharmacodynamics properties of Gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukaemia FLT3-ITD patients.
暂无分享，去创建一个
P. Rousselot | S. Mourah | E. Raffoux | D. Ghez | É. Jacqz-Aigrain | H. Sauvageon | L. Goldwirt | E. Lengliné | L. Kelly | A. Cabannes-Hamy | M. Kohn | N. Vignal | Justine Siavellis | T. Braun | Alexandre Puissant